Home › NCT05521607

Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)

Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice in Newborns with High Melanin Content (Chicago)

Who can join

1 Day – 14 Days · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Infants born with gestational age \> 35 weeks.
* Birth weight ≥ 1800 grams
* Age 1 - 14 days
* Infants requiring a TSB blood sample for clinically suspected jaundice as part of standard care

Exclusion Criteria:

* Infants showing signs of inborn disease.
* Infants with skin rash or other skin disease that affects the skin where measurements are performed.
* Infants transferred to the pediatric ward for medical treatment.
* Infants that have received phototherapy in the last 24 hours

About the study

A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) to enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.

What is being tested

• Picterus Jaundice Pro (JP) (device)

Sponsor: Picterus AS · Participants: 250 · Started: Jan 6, 2023

Contact the study team

• Jeanmarie Schied, MD · Phone: 7737029200

Official record on ClinicalTrials.gov — NCT05521607

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.